Constitutive activation of JAKs sustains persistent STAT3 phosphorylation, which in turn promotes key oncogenic processes, including tumor cell proliferation, survival, metastasis, immune evasion, and chemoresistance (Dinakar et al., 2022; Johnson et al., 2018; Yu et al., 2014). The gene discussed is STAT3; the disease is neoplasm.